Medical Devices; Cardiovascular Devices; Classification of the Mechanical Deviation Device for Esophageal Protection During Cardiac Ablation Procedures
Key claim: The FDA is placing a device that physically moves the esophagus away from the heart during cardiac ablation into the moderate-risk (class II) category with special controls, making it easier for similar devices to reach patients.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the mechanical deviation device for esophageal protection during cardiac ablation procedures into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the mechanical deviation device for esophageal protection during cardiac ablation procedures. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Why this matters
Classifying this esophageal-protection device as Class II with special controls sets a defined regulatory pathway for accessories used to prevent thermal injury during cardiac ablation, letting future similar devices reach patients via 510(k) rather than premarket approval. For patients undergoing atrial fibrillation ablation, this could expand availability of tools that reduce the rare but serious risk of atrioesophageal fistula.